Pulmonx Corporation (LUNG) Tops Q1 EPS by 3c

Pulmonx Corporation (NASDAQ: LUNG) reported Q1 EPS of ($0.36), $0.03 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $22.5 million versus the consensus estimate of $22.03 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip
• Increasing unusual option volume: DKS QFIN NVD GTM ROK TENB OKTA LDI URBN LABX CRMG RSI COSM ANF APO TEN TIGR
• Agilent (A) PT Raised to $180 at TD Cowen